ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pediatric Vaccines Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-13M6952
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pediatric Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pediatric Vaccines Market Research Report 2025

Code: QYRE-Auto-13M6952
Report
September 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Pfizer Inc
Sanofi
Astrazeneca plc
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin Ltd
S.K. Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
SINOVAC BIOTECH
Bharat Biotech
Crucell
Dynavax
Serum Institute of India

Pediatric Vaccines Market Size

The global market for Pediatric Vaccines was valued at US$ 34000 million in the year 2024 and is projected to reach a revised size of US$ 49850 million by 2031, growing at a CAGR of 5.7% during the forecast period.

Pediatric Vaccines Market

Pediatric Vaccines Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Vaccines.
The Pediatric Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pediatric Vaccines Market Report

Report Metric Details
Report Name Pediatric Vaccines Market
Accounted market size in year US$ 34000 million
Forecasted market size in 2031 US$ 49850 million
CAGR 5.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Diphtheria
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Meningococcal Diseases
  • Others
Segment by Application
  • Newborn
  • Infant
  • Child
  • Dolescent
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic, Baxter, LG Life Sciences, Lupin, S K Chemicals, Mitsubishi Tanabe Pharma, Janssen, Shenzhen Kangtai Biological Products, Sinovac Biotech, Bharat Biotech, Crucell, Dynavax, Serum Institute of India
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pediatric Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pediatric Vaccines Market growing?

Ans: The Pediatric Vaccines Market witnessing a CAGR of 5.7% during the forecast period 2025-2031.

What is the Pediatric Vaccines Market size in 2031?

Ans: The Pediatric Vaccines Market size in 2031 will be US$ 49850 million.

Who are the main players in the Pediatric Vaccines Market report?

Ans: The main players in the Pediatric Vaccines Market are GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic, Baxter, LG Life Sciences, Lupin, S K Chemicals, Mitsubishi Tanabe Pharma, Janssen, Shenzhen Kangtai Biological Products, Sinovac Biotech, Bharat Biotech, Crucell, Dynavax, Serum Institute of India

What are the Application segmentation covered in the Pediatric Vaccines Market report?

Ans: The Applications covered in the Pediatric Vaccines Market report are Newborn, Infant, Child, Dolescent

What are the Type segmentation covered in the Pediatric Vaccines Market report?

Ans: The Types covered in the Pediatric Vaccines Market report are Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Others

1 Pediatric Vaccines Market Overview
1.1 Product Definition
1.2 Pediatric Vaccines by Type
1.2.1 Global Pediatric Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Others
1.3 Pediatric Vaccines by Application
1.3.1 Global Pediatric Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.3.5 Dolescent
1.4 Global Pediatric Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Vaccines Revenue 2020-2031
1.4.2 Global Pediatric Vaccines Sales 2020-2031
1.4.3 Global Pediatric Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pediatric Vaccines Market Competition by Manufacturers
2.1 Global Pediatric Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pediatric Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pediatric Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pediatric Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pediatric Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Pediatric Vaccines, Date of Enter into This Industry
2.8 Global Pediatric Vaccines Market Competitive Situation and Trends
2.8.1 Global Pediatric Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pediatric Vaccines Players Market Share by Revenue
2.8.3 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pediatric Vaccines Market Scenario by Region
3.1 Global Pediatric Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pediatric Vaccines Sales by Region: 2020-2031
3.2.1 Global Pediatric Vaccines Sales by Region: 2020-2025
3.2.2 Global Pediatric Vaccines Sales by Region: 2026-2031
3.3 Global Pediatric Vaccines Revenue by Region: 2020-2031
3.3.1 Global Pediatric Vaccines Revenue by Region: 2020-2025
3.3.2 Global Pediatric Vaccines Revenue by Region: 2026-2031
3.4 North America Pediatric Vaccines Market Facts & Figures by Country
3.4.1 North America Pediatric Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pediatric Vaccines Sales by Country (2020-2031)
3.4.3 North America Pediatric Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pediatric Vaccines Market Facts & Figures by Country
3.5.1 Europe Pediatric Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pediatric Vaccines Sales by Country (2020-2031)
3.5.3 Europe Pediatric Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Pediatric Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pediatric Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Pediatric Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pediatric Vaccines Market Facts & Figures by Country
3.7.1 Latin America Pediatric Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pediatric Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Pediatric Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pediatric Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pediatric Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Vaccines Sales by Type (2020-2031)
4.1.1 Global Pediatric Vaccines Sales by Type (2020-2025)
4.1.2 Global Pediatric Vaccines Sales by Type (2026-2031)
4.1.3 Global Pediatric Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Pediatric Vaccines Revenue by Type (2020-2031)
4.2.1 Global Pediatric Vaccines Revenue by Type (2020-2025)
4.2.2 Global Pediatric Vaccines Revenue by Type (2026-2031)
4.2.3 Global Pediatric Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Pediatric Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pediatric Vaccines Sales by Application (2020-2031)
5.1.1 Global Pediatric Vaccines Sales by Application (2020-2025)
5.1.2 Global Pediatric Vaccines Sales by Application (2026-2031)
5.1.3 Global Pediatric Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Pediatric Vaccines Revenue by Application (2020-2031)
5.2.1 Global Pediatric Vaccines Revenue by Application (2020-2025)
5.2.2 Global Pediatric Vaccines Revenue by Application (2026-2031)
5.2.3 Global Pediatric Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Pediatric Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Pediatric Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Pediatric Vaccines Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi Pediatric Vaccines Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Pediatric Vaccines Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Pediatric Vaccines Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Takeda Pharmaceutical
6.7.1 Takeda Pharmaceutical Company Information
6.7.2 Takeda Pharmaceutical Description and Business Overview
6.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
6.7.5 Takeda Pharmaceutical Recent Developments/Updates
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Company Information
6.8.2 Bavarian Nordic Description and Business Overview
6.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
6.8.5 Bavarian Nordic Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Company Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Baxter Pediatric Vaccines Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 LG Life Sciences
6.10.1 LG Life Sciences Company Information
6.10.2 LG Life Sciences Description and Business Overview
6.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 LG Life Sciences Pediatric Vaccines Product Portfolio
6.10.5 LG Life Sciences Recent Developments/Updates
6.11 Lupin
6.11.1 Lupin Company Information
6.11.2 Lupin Description and Business Overview
6.11.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lupin Pediatric Vaccines Product Portfolio
6.11.5 Lupin Recent Developments/Updates
6.12 S K Chemicals
6.12.1 S K Chemicals Company Information
6.12.2 S K Chemicals Description and Business Overview
6.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 S K Chemicals Pediatric Vaccines Product Portfolio
6.12.5 S K Chemicals Recent Developments/Updates
6.13 Mitsubishi Tanabe Pharma
6.13.1 Mitsubishi Tanabe Pharma Company Information
6.13.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
6.13.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.14 Janssen
6.14.1 Janssen Company Information
6.14.2 Janssen Description and Business Overview
6.14.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Janssen Pediatric Vaccines Product Portfolio
6.14.5 Janssen Recent Developments/Updates
6.15 Shenzhen Kangtai Biological Products
6.15.1 Shenzhen Kangtai Biological Products Company Information
6.15.2 Shenzhen Kangtai Biological Products Description and Business Overview
6.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
6.15.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.16 Sinovac Biotech
6.16.1 Sinovac Biotech Company Information
6.16.2 Sinovac Biotech Description and Business Overview
6.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
6.16.5 Sinovac Biotech Recent Developments/Updates
6.17 Bharat Biotech
6.17.1 Bharat Biotech Company Information
6.17.2 Bharat Biotech Description and Business Overview
6.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Bharat Biotech Pediatric Vaccines Product Portfolio
6.17.5 Bharat Biotech Recent Developments/Updates
6.18 Crucell
6.18.1 Crucell Company Information
6.18.2 Crucell Description and Business Overview
6.18.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Crucell Pediatric Vaccines Product Portfolio
6.18.5 Crucell Recent Developments/Updates
6.19 Dynavax
6.19.1 Dynavax Company Information
6.19.2 Dynavax Description and Business Overview
6.19.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Dynavax Pediatric Vaccines Product Portfolio
6.19.5 Dynavax Recent Developments/Updates
6.20 Serum Institute of India
6.20.1 Serum Institute of India Company Information
6.20.2 Serum Institute of India Description and Business Overview
6.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Serum Institute of India Pediatric Vaccines Product Portfolio
6.20.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Vaccines Industry Chain Analysis
7.2 Pediatric Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Vaccines Production Mode & Process Analysis
7.4 Pediatric Vaccines Sales and Marketing
7.4.1 Pediatric Vaccines Sales Channels
7.4.2 Pediatric Vaccines Distributors
7.5 Pediatric Vaccines Customer Analysis
8 Pediatric Vaccines Market Dynamics
8.1 Pediatric Vaccines Industry Trends
8.2 Pediatric Vaccines Market Drivers
8.3 Pediatric Vaccines Market Challenges
8.4 Pediatric Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Pfizer Inc
Sanofi
Astrazeneca plc
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin Ltd
S.K. Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
SINOVAC BIOTECH
Bharat Biotech
Crucell
Dynavax
Serum Institute of India
List of Tables
 Table 1. Global Pediatric Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pediatric Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pediatric Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pediatric Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pediatric Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pediatric Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pediatric Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pediatric Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pediatric Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pediatric Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pediatric Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Pediatric Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pediatric Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pediatric Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pediatric Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Pediatric Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pediatric Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Pediatric Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pediatric Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Pediatric Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pediatric Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Pediatric Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pediatric Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pediatric Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pediatric Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pediatric Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pediatric Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pediatric Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pediatric Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pediatric Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pediatric Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pediatric Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pediatric Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pediatric Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pediatric Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pediatric Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pediatric Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pediatric Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pediatric Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pediatric Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pediatric Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pediatric Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pediatric Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pediatric Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pediatric Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pediatric Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pediatric Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Pediatric Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Pediatric Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Pediatric Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Pediatric Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pediatric Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pediatric Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Pediatric Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Pediatric Vaccines Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Pediatric Vaccines Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Pediatric Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Pediatric Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Pediatric Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Pediatric Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Pediatric Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pediatric Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pediatric Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Pediatric Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Pediatric Vaccines Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Pediatric Vaccines Price (USD/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Pediatric Vaccines Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Pediatric Vaccines Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Pediatric Vaccines Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Sanofi Company Information
 Table 86. Sanofi Description and Business Overview
 Table 87. Sanofi Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Sanofi Pediatric Vaccines Product
 Table 89. Sanofi Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Pediatric Vaccines Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. Novartis Company Information
 Table 96. Novartis Description and Business Overview
 Table 97. Novartis Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Novartis Pediatric Vaccines Product
 Table 99. Novartis Recent Developments/Updates
 Table 100. Takeda Pharmaceutical Company Information
 Table 101. Takeda Pharmaceutical Description and Business Overview
 Table 102. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Takeda Pharmaceutical Pediatric Vaccines Product
 Table 104. Takeda Pharmaceutical Recent Developments/Updates
 Table 105. Bavarian Nordic Company Information
 Table 106. Bavarian Nordic Description and Business Overview
 Table 107. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Bavarian Nordic Pediatric Vaccines Product
 Table 109. Bavarian Nordic Recent Developments/Updates
 Table 110. Baxter Company Information
 Table 111. Baxter Description and Business Overview
 Table 112. Baxter Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Baxter Pediatric Vaccines Product
 Table 114. Baxter Recent Developments/Updates
 Table 115. LG Life Sciences Company Information
 Table 116. LG Life Sciences Description and Business Overview
 Table 117. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. LG Life Sciences Pediatric Vaccines Product
 Table 119. LG Life Sciences Recent Developments/Updates
 Table 120. Lupin Company Information
 Table 121. Lupin Description and Business Overview
 Table 122. Lupin Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Lupin Pediatric Vaccines Product
 Table 124. Lupin Recent Developments/Updates
 Table 125. S K Chemicals Company Information
 Table 126. S K Chemicals Description and Business Overview
 Table 127. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. S K Chemicals Pediatric Vaccines Product
 Table 129. S K Chemicals Recent Developments/Updates
 Table 130. Mitsubishi Tanabe Pharma Company Information
 Table 131. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 132. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Mitsubishi Tanabe Pharma Pediatric Vaccines Product
 Table 134. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 135. Janssen Company Information
 Table 136. Janssen Description and Business Overview
 Table 137. Janssen Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Janssen Pediatric Vaccines Product
 Table 139. Janssen Recent Developments/Updates
 Table 140. Shenzhen Kangtai Biological Products Company Information
 Table 141. Shenzhen Kangtai Biological Products Description and Business Overview
 Table 142. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Shenzhen Kangtai Biological Products Pediatric Vaccines Product
 Table 144. Shenzhen Kangtai Biological Products Recent Developments/Updates
 Table 145. Sinovac Biotech Company Information
 Table 146. Sinovac Biotech Description and Business Overview
 Table 147. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Sinovac Biotech Pediatric Vaccines Product
 Table 149. Sinovac Biotech Recent Developments/Updates
 Table 150. Bharat Biotech Company Information
 Table 151. Bharat Biotech Description and Business Overview
 Table 152. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Bharat Biotech Pediatric Vaccines Product
 Table 154. Bharat Biotech Recent Developments/Updates
 Table 155. Crucell Company Information
 Table 156. Crucell Description and Business Overview
 Table 157. Crucell Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. Crucell Pediatric Vaccines Product
 Table 159. Crucell Recent Developments/Updates
 Table 160. Dynavax Company Information
 Table 161. Dynavax Description and Business Overview
 Table 162. Dynavax Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 163. Dynavax Pediatric Vaccines Product
 Table 164. Dynavax Recent Developments/Updates
 Table 165. Serum Institute of India Company Information
 Table 166. Serum Institute of India Description and Business Overview
 Table 167. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 168. Serum Institute of India Pediatric Vaccines Product
 Table 169. Serum Institute of India Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Pediatric Vaccines Distributors List
 Table 173. Pediatric Vaccines Customers List
 Table 174. Pediatric Vaccines Market Trends
 Table 175. Pediatric Vaccines Market Drivers
 Table 176. Pediatric Vaccines Market Challenges
 Table 177. Pediatric Vaccines Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pediatric Vaccines
 Figure 2. Global Pediatric Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pediatric Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Diphtheria Product Picture
 Figure 5. Influenza Product Picture
 Figure 6. Hepatitis Product Picture
 Figure 7. Pneumococcal Diseases Product Picture
 Figure 8. Meningococcal Diseases Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Pediatric Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Pediatric Vaccines Market Share by Application: 2024 & 2031
 Figure 12. Newborn
 Figure 13. Infant
 Figure 14. Child
 Figure 15. Dolescent
 Figure 16. Global Pediatric Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Pediatric Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Pediatric Vaccines Sales (2020-2031) & (K Units)
 Figure 19. Global Pediatric Vaccines Average Price (USD/Unit) & (2020-2031)
 Figure 20. Pediatric Vaccines Report Years Considered
 Figure 21. Pediatric Vaccines Sales Share by Manufacturers in 2024
 Figure 22. Global Pediatric Vaccines Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Pediatric Vaccines Players: Market Share by Revenue in Pediatric Vaccines in 2024
 Figure 24. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Pediatric Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Pediatric Vaccines Sales Market Share by Country (2020-2031)
 Figure 27. North America Pediatric Vaccines Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Pediatric Vaccines Sales Market Share by Country (2020-2031)
 Figure 31. Europe Pediatric Vaccines Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Pediatric Vaccines Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Pediatric Vaccines Revenue Market Share by Region (2020-2031)
 Figure 39. China Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. China Taiwan Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Pediatric Vaccines Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Pediatric Vaccines Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Colombia Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Pediatric Vaccines Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Pediatric Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Pediatric Vaccines by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Pediatric Vaccines by Type (2020-2031)
 Figure 61. Global Pediatric Vaccines Price (USD/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Pediatric Vaccines by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Pediatric Vaccines by Application (2020-2031)
 Figure 64. Global Pediatric Vaccines Price (USD/Unit) by Application (2020-2031)
 Figure 65. Pediatric Vaccines Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Paediatric Vaccine Market
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Oncology Treatment Market Research Report 2025
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Diphtheria Tetanus Pertussis Mix Vaccine for Children Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attenuated Vaccine Market Research Report 2025
Global Trivalent Flu Vaccine Market Insights Forecast to 2030
Global Vaccine Cooler Market Research Report 2025
Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Glass Vials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vaccines Market Research Report 2025
Global Livestock Vaccine Market Research Report 2025
Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Quadrivalent Flu Vaccine Market Insights Forecast to 2030
Clinical Trials of Drugs and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions